Synergistic Immuno Photothermal Nanotherapy (SYMPHONY) for the Treatment of Unresectable and Metastatic Cancers

Abstract Metastatic spread is the mechanism in more than 90 percent of cancer deaths and current therapeutic options, such as systemic chemotherapy, are often ineffective. Here we provide a proof of principle for a novel two-pronged modality referred to as Synergistic Immuno Photothermal Nanotherapy...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yang Liu, Paolo Maccarini, Gregory M. Palmer, Wiguins Etienne, Yulin Zhao, Chen-Ting Lee, Xiumei Ma, Brant A. Inman, Tuan Vo-Dinh
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/7a7a54c93aa543e3b9bbc73ed1387d7a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7a7a54c93aa543e3b9bbc73ed1387d7a
record_format dspace
spelling oai:doaj.org-article:7a7a54c93aa543e3b9bbc73ed1387d7a2021-12-02T16:06:47ZSynergistic Immuno Photothermal Nanotherapy (SYMPHONY) for the Treatment of Unresectable and Metastatic Cancers10.1038/s41598-017-09116-12045-2322https://doaj.org/article/7a7a54c93aa543e3b9bbc73ed1387d7a2017-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-09116-1https://doaj.org/toc/2045-2322Abstract Metastatic spread is the mechanism in more than 90 percent of cancer deaths and current therapeutic options, such as systemic chemotherapy, are often ineffective. Here we provide a proof of principle for a novel two-pronged modality referred to as Synergistic Immuno Photothermal Nanotherapy (SYMPHONY) having the potential to safely eradicate both primary tumors and distant metastatic foci. Using a combination of immune-checkpoint inhibition and plasmonic gold nanostar (GNS)–mediated photothermal therapy, we were able to achieve complete eradication of primary treated tumors and distant untreated tumors in some mice implanted with the MB49 bladder cancer cells. Delayed rechallenge with MB49 cancer cells injection in mice that appeared cured by SYMPHONY did not lead to new tumor formation after 60 days observation, indicating that SYMPHONY treatment induced effective long-lasting immunity against MB49 cancer cells.Yang LiuPaolo MaccariniGregory M. PalmerWiguins EtienneYulin ZhaoChen-Ting LeeXiumei MaBrant A. InmanTuan Vo-DinhNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-6 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Yang Liu
Paolo Maccarini
Gregory M. Palmer
Wiguins Etienne
Yulin Zhao
Chen-Ting Lee
Xiumei Ma
Brant A. Inman
Tuan Vo-Dinh
Synergistic Immuno Photothermal Nanotherapy (SYMPHONY) for the Treatment of Unresectable and Metastatic Cancers
description Abstract Metastatic spread is the mechanism in more than 90 percent of cancer deaths and current therapeutic options, such as systemic chemotherapy, are often ineffective. Here we provide a proof of principle for a novel two-pronged modality referred to as Synergistic Immuno Photothermal Nanotherapy (SYMPHONY) having the potential to safely eradicate both primary tumors and distant metastatic foci. Using a combination of immune-checkpoint inhibition and plasmonic gold nanostar (GNS)–mediated photothermal therapy, we were able to achieve complete eradication of primary treated tumors and distant untreated tumors in some mice implanted with the MB49 bladder cancer cells. Delayed rechallenge with MB49 cancer cells injection in mice that appeared cured by SYMPHONY did not lead to new tumor formation after 60 days observation, indicating that SYMPHONY treatment induced effective long-lasting immunity against MB49 cancer cells.
format article
author Yang Liu
Paolo Maccarini
Gregory M. Palmer
Wiguins Etienne
Yulin Zhao
Chen-Ting Lee
Xiumei Ma
Brant A. Inman
Tuan Vo-Dinh
author_facet Yang Liu
Paolo Maccarini
Gregory M. Palmer
Wiguins Etienne
Yulin Zhao
Chen-Ting Lee
Xiumei Ma
Brant A. Inman
Tuan Vo-Dinh
author_sort Yang Liu
title Synergistic Immuno Photothermal Nanotherapy (SYMPHONY) for the Treatment of Unresectable and Metastatic Cancers
title_short Synergistic Immuno Photothermal Nanotherapy (SYMPHONY) for the Treatment of Unresectable and Metastatic Cancers
title_full Synergistic Immuno Photothermal Nanotherapy (SYMPHONY) for the Treatment of Unresectable and Metastatic Cancers
title_fullStr Synergistic Immuno Photothermal Nanotherapy (SYMPHONY) for the Treatment of Unresectable and Metastatic Cancers
title_full_unstemmed Synergistic Immuno Photothermal Nanotherapy (SYMPHONY) for the Treatment of Unresectable and Metastatic Cancers
title_sort synergistic immuno photothermal nanotherapy (symphony) for the treatment of unresectable and metastatic cancers
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/7a7a54c93aa543e3b9bbc73ed1387d7a
work_keys_str_mv AT yangliu synergisticimmunophotothermalnanotherapysymphonyforthetreatmentofunresectableandmetastaticcancers
AT paolomaccarini synergisticimmunophotothermalnanotherapysymphonyforthetreatmentofunresectableandmetastaticcancers
AT gregorympalmer synergisticimmunophotothermalnanotherapysymphonyforthetreatmentofunresectableandmetastaticcancers
AT wiguinsetienne synergisticimmunophotothermalnanotherapysymphonyforthetreatmentofunresectableandmetastaticcancers
AT yulinzhao synergisticimmunophotothermalnanotherapysymphonyforthetreatmentofunresectableandmetastaticcancers
AT chentinglee synergisticimmunophotothermalnanotherapysymphonyforthetreatmentofunresectableandmetastaticcancers
AT xiumeima synergisticimmunophotothermalnanotherapysymphonyforthetreatmentofunresectableandmetastaticcancers
AT brantainman synergisticimmunophotothermalnanotherapysymphonyforthetreatmentofunresectableandmetastaticcancers
AT tuanvodinh synergisticimmunophotothermalnanotherapysymphonyforthetreatmentofunresectableandmetastaticcancers
_version_ 1718384850370560000